Nanotechnology for Medicine and Health Care MSc

**The information provided on this page was correct at the time of publication (November 2024). For complete and up-to-date information about this course, please visit the relevant University of Oxford course page via www.graduate.ox.ac.uk/ucas.** <br/><br/>The University of Oxford Institute of Biomedical Engineering (Department of Engineering Science) and the Department for Continuing Education, in collaboration with Begbroke Science Park, offer the part-time MSc in Nanotechnology for Medicine and Health Care. <br/><br/>This advanced modular course is delivered by leading scientists and experts in this rapidly developing field and has been specifically designed for those who would value a part-time modular learning structure, for example those in full-time employment.<br/><br/>Nanomedicine is at the forefront of modern healthcare. Nanoparticles offer a new platform for drug delivery that can extend the patent life of drugs, but also greatly increase the targeting and effectiveness of therapy. They can also enhance most of the medical imaging modalities, and in some cases offer a combined diagnostic and therapy, now called theranostics.<br/><br/>Nanoparticle-based medicines are now becoming part of the mainstream approaches for diagnostics and therapy. A 2016 review identified 51 FDA-approved nanomedicines and 77 products undergoing clinical trials. By August 2018, 151 clinical trials using nanomaterials were completed or underway. Whilst most of these used fairly simple single-phase materials, there is a growing trend for more complex multi-functional nanomaterials and there are exciting possibilities ahead. Prime examples being the recent use of lipid nanoparticle (LNP)-based agents to deliver nucleotide payload for vaccination (COVID-19 Vaccines | FDA) and in liver directed gene therapy approaches (FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease | FDA). In addition to which a range of nanoscale viral-based vectors continue to make progress and achieve approval (FDA Approves First Gene Therapy to Treat Adults with Hemophilia B | FDA).<br/><br/>Nanotechnology is providing the basis for many of the new regenerative medicine approaches that are based on artificial scaffold structures and it offers solutions for many of the new generation of point-of-care biosensors and some of the advanced gene sequencing instrumentation. There are already early indications of improved healthcare outcomes, and the creation of new business and industry.<br/><br/>The University of Oxford Institute of Biomedical Engineering (IBME), an Institute within the Department for Engineering Science, is a world-class interdisciplinary centre for biomedical engineering research, where engineers and clinicians collaborate to address unmet needs in the prevention, early diagnosis and treatment of major diseases and conditions. The Institute’s core research missions are to develop novel medical devices, technology and systems capable of delivering substantial healthcare benefit, and to translate new engineering technologies into clinical practice.<br/><br/>The MSc in Nanotechnology for Medicine and Health Care draws on the world-class research and teaching in nanotechnology and nanomedicine at the University of Oxford and aims to provide you with the necessary training to enable you to understand the principles of nanotechnology and its application in medical research and clinical practice.<br/><br/>The programme will appeal to professionals working in the commercial or healthcare sectors who develop or use nanotechnology in their work, including:<br/><br/><br/>- biomedical engineers<br/><br/><br/>- materials scientists<br/><br/><br/>- biotech-entrepreneurs<br/><br/><br/>- medical practitioners and dentists<br/><br/><br/>- chemists and pharmacists<br/><br/><br/>- electrical engineers<br/><br/><br/>- project managers in related industries<br/><br/><br/>- patent agents and patent lawyers<br/><br/><br/>- legislators<br/><br/><br/>- clinical research fellows, graduates and other researchers in a related area of science.<br/>